Education
About Us
Working with TipRanks
Follow Us
Affimed Therapeutics (CH:AFMD)
:AFMD
Total Valuation
Affimed has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Affimed has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Affimed’s return on equity (ROE) is -1.83 and return on invested capital (ROIC) is -137.41%.
Return on Equity (ROE)-1.83
Return on Assets (ROA)-1.09
Return on Invested Capital (ROIC)-137.41%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee108.88K
Profits Per Employee-1.39M
Employee Count76
Asset Turnover0.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Affimed is -0.80. Affimed’s PEG ratio is -0.05.
PE Ratio-0.80
PS Ratio―
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-0.74
Price to Operating Cash Flow-0.77
PEG Ratio-0.05
Income Statement
In the last 12 months, Affimed had revenue of 8.28M and earned -105.94M in profits. Earnings per share was -7.09.
Revenue8.28M
Gross Profit8.28M
Operating Income-106.66M
Pretax Income-105.94M
Net Income-105.94M
EBITDA-102.38M
Earnings Per Share (EPS)-7.09
Cash Flow
In the last 12 months, operating cash flow was -76.90M and capital expenditures -534.00K, giving a free cash flow of -77.44M billion.
Operating Cash Flow-76.90M
Free Cash Flow-77.44M
Free Cash Flow per Share―
Dividends & Yields
Affimed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Affimed upcoming earnings date is May 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend Date―
Financial Position
Affimed as a current ratio of 3.25, with Debt / Equity ratio of 74.96%
Current Ratio3.25
Quick Ratio3.23
Debt to Market Cap0.14
Net Debt to EBITDA0.19
Interest Coverage Ratio-59.06
Taxes
In the past 12 months, Affimed has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Affimed EV to EBITDA ratio is -0.64, with an EV/FCF ratio of -0.57.
EV to Sales7.89
EV to EBITDA-0.64
EV to Free Cash Flow-0.57
EV to Operating Cash Flow-0.59
Balance Sheet
Affimed has $24.94M in cash and marketable securities with €4.80M in debt, giving a net cash position of -$12.05M billion.
Cash & Marketable Securities$24.94M
Total Debt€4.80M
Net Cash-$12.05M
Net Cash Per Share―
Tangible Book Value Per Share$3.87
Margins
Gross margin is 100.00%, with operating margin of -1288.95%, and net profit margin of -1280.22%.
Gross Margin100.00%
Operating Margin-1288.95%
Pretax Margin-1280.18%
Net Profit Margin-1280.22%
EBITDA Margin-1237.22%
EBIT Margin-1258.36%
Analyst Forecast
The average price target for Affimed is $9.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.29
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―